Download Docs
Export

RETRIG

99245347 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed June 20, 2025
Serial No. 99245347
Examining Attorney null
Class Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations; 005; 006; 018; 044; 046; 051; 052
RETRIG
Case Type Trademark
Status A first request for extension of time to file a Statement of Use has been granted.
Last Updated: 1 week, 1 day ago
Filing Date # Docket Text